Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

THE WOODLANDS, Texas, May 28, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on June 4, 2026 at 2:00 p.m. ET in New York City.

The live event and a replay of the presentation can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/.

About Lexicon Pharmaceuticals    
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Lexicon has a pipeline of drug candidates in discovery, preclinical, and clinical development in neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and other cardiometabolic indications. For additional information, please visit www.lexpharma.com.   

For Media Inquiries: 
Dave Belian 
Lexicon Pharmaceuticals, Inc. 
[email protected]  
  
For Investor Inquiries: 
Lisa DeFrancesco 
Lexicon Pharmaceuticals, Inc. 
[email protected] 

You May Also Be Interested In

• North Carolina Central University alumnus and retired University of North Carolina at Chapel Hill professor joins the Thurgood Marshall College Fund as distinguished faculty-in-residence
• Questor Technology Reports Progress on Execution of Phase III Shareholder Value Creation Plan
• Forge Resources Advances La Estrella as Coal Prices Hold Strong and Colombia's New Government Reopens the Resource Sector